Elinzanetant is a non-hormonal compound that acts as a selective dual antagonist of neurokinin 1 (NK-1) and neurokinin 3 (NK-3) receptors. It is used as a pharmaceutical raw material in the manufacturing of products for managing moderate to severe vasomotor symptoms associated with menopause.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 929046-33-3
Gadoterate meglumine
pharmaceutical raw material
Guaifenesin
pharmaceutical raw material
(RS)-methoxyphenamine
pharmaceutical raw material
5-azacytosine
pharmaceutical raw material
N-[6-[(7S,9aS)-7-(hydroxymethyl)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-4-(4-fluoro-2-methylphenyl)-3-pyridinyl]-2-[3,5-bis(trifluoromethyl)phenyl]-N,2-dimethylpropanamide
DWRIJNIPBUFCQS-DQEYMECFSA-N
CC1=C(C=CC(=C1)F)C2=CC(=NC=C2N(C)C(=O)C(C)(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)N4C[C@H]5COCCN5C[C@H]4CO